Serum Levels of Interleukin-10 and Interleukin-12 Predict Early, Spontaneous Hepatitis B Virus e Antigen Seroconversion
Background & Aims
This prospective cohort study aimed to determine the effect of cytokines on spontaneous hepatitis B e antigen (HBeAg) seroconversion in patients with chronic hepatitis B virus (HBV) infection.
Methods
Polymorphisms in interleukin (IL)-2, IL-4, IL-10, IL-12β, and interferon-γ were evaluated in 288 HBeAg-positive chronic HBV patients (median initial age, 8.6 years; median follow-up duration, 19.3 years). Serum cytokine levels were determined in 154 subjects (53.5%) before and after HBeAg seroconversion by enzyme-linked immunosorbent assay analysis. Peripheral blood mononuclear cells (PBMC) were isolated from patients with chronic HBV infection and stimulated with HBV core antigen (HBcAg); data on cytokine genotypes and phenotypes were compared.
Results
The IL-10-1082 G/G and IL-12β -10993C/G genotypes predicted early, spontaneous HBeAg seroconversion (hazard ratio [HRs] = 3.43 and 1.54; P < .001, and P < .004, respectively), based on multivariate survival analysis. The IL-10 -1082 G/G genotype was associated with higher serum levels of IL-10 and IL-12; the IL-12β -10993 C/G genotype predicted higher levels of IL-12 secretion by PBMC after in vitro HBcAg stimulation (P = .04). Higher levels of serum IL-12 (>45 pg/mL) and IL-10 (>70 pg/mL) were associated with early, spontaneous HBeAg seroconversion (HR = 1.52 and 1.48; P = .04 and .02, respectively).
Conclusions
The IL-10-1082 G/G is associated with higher serum IL-10 and IL-12 levels and IL-12β -10993 C/G is associated with increased secretion of IL-12 in response to HBcAg stimulation of PBMC. Both genotypes are associated with early, spontaneous HBeAg seroconversion. Higher serum levels of IL-10 and IL-12 in HBeAg-positive patients are correlated with early, spontaneous HBeAg seroconversion.
Abbreviations used in this paper: ALT, alanine aminotransferase, HBcAg, HBV core antigen, HBeAg, hepatitis B e antigen, HBV, hepatitis B virus, HR, hazard ratio, IL, interleukin, PBMC, peripheral blood mononuclear cells, PCR, polymerase chain reaction, SNP, single nucleotide polymorphism, Th1 and Th2, types 1 and 2 helper T lymphocyte
To access this article, please choose from the options below
Conflicts of interest The authors disclose no conflicts.
Funding This work was supported by grants from the National Taiwan University Hospital and Taipei Veterans General Hospital (96-VN-12, 97-VN-05, 98-VN-06) and a grant from the National Science Council, Executive Yuan, Taiwan (NSC-97-2314-B-002-072-MY2).
PII: S0016-5085(09)01659-X
doi:10.1053/j.gastro.2009.09.018
© 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
Refers to erratum:
- Correction , 04 April 2011

